Ads
related to: fda
Search results
Earnings call: Lumos Pharma gears up for Phase 3 trial of LUM-201 By Investing.com
Investing.com· 58 minutes agoThe company has completed a constructive End-of-Phase 2 Meeting with the FDA and is planning to...
FDA Concludes that Tara Flour is Not GRAS
The National Law Review· 6 hours agoFood and Drug Administration FDA publishes assessment concluding that tara flour does not meet generally recognized as safe GRAS as unapproved food...
FDA approves self-collection screening for virus that causes cervical cancer - The Boston Globe
The Boston Globe· 2 hours ago“It provides women who might not have otherwise had the opportunity — or inclination — to get screened the chance do so,” said Erin Kobetz, associate director for community outreach and engagement ...
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Benzinga via Yahoo Finance· 5 hours agoTuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
CNN via AOL· 2 hours agoInstead of a traditional speculum-involved pelvic exam to screen for cervical cancer, the US Food...
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Zacks via Yahoo Finance· 8 hours agoPer the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a...
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
Zacks via Yahoo Finance· 1 day agoPhilips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power...
FDA approves HPV self-test kit
UPI· 7 hours agoEach year, about 11,500 U.S. women are diagnosed with cervical cancer and about 4,000 women die from it, according to the U.S. Centers for Disease...
After FDA warning, Getinge trims sales of heart devices
Becker’s Hospital Review· 16 hours agoAfter the FDA instructed healthcare facilities to avoid using two Getinge heart devices because of quality and safety concerns, the company stopped promoting the products.
Earnings call: Palatin Technologies reports Q3 results, plans new trials By Investing.com
Investing.com· 41 minutes agoPalatin Technologies, Inc. (NYSE:PTN) has disclosed its financial results for the third quarter of...